Literature DB >> 9892397

Lymphoproliferative responses to human herpesvirus-6 variant A and variant B in healthy adults.

F Z Wang1, H Dahl, P Ljungman, A Linde.   

Abstract

Human herpesvirus-6 (HHV-6) isolates can be classified into variants A and B, and over 95% of people older than 2 years of age are seropositive for either or both variants. However, the prevalence of the two HHV-6 variants is still not defined since the serological methods used at present cannot discriminate one variant from the other. Lymphoproliferative responses to glycine extracted cellular antigens from human herpes-virus-6 (HHV-6) GS strain (variant A)- and Z 29 strain (variant B)-infected T-lymphoid cell lines were examined in healthy Swedish and Japanese adults. Nine of 36 (25%) persons had responses to the GS antigen, while 21/36 (58%) had responses to the Z 29 antigen (P=0.008). Individuals with low anti-HHV-6 IgG titers (< or = 320) were more likely to respond to the Z 29 antigen than to the GS antigen (P=0.006), while there was no difference in those with high anti-HHV-6 IgG titers (> or =1280). Three of 7 Japanese adults had lymphoproliferative responses to the GS antigen compared with 6/29 Swedes (not significant), and 7/7 Japanese had lymphoproliferative responses to the Z 29 antigen compared with 14/29 Swedes (P=0.03). Lymphoproliferative responses were neither related with the presence of HHV-6 DNA nor related with the presence of HHV-7 DNA in peripheral blood cells. These results suggest a higher prevalence of HHV-6 variant B than variant A in both Swedes and Japanese adults, and possibly a difference in either the HHV-6 virus strains and/or the nature of immune response of Swede and Japanese.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9892397

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

1.  Similar humoral and cellular immunological reactivities to human herpesvirus 6 in patients with multiple sclerosis and controls.

Authors:  M Enbom; F Z Wang; S Fredrikson; C Martin; H Dahl; A Linde
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

Review 2.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

Review 3.  Immune response to HHV-6 and implications for immunotherapy.

Authors:  Aniuska Becerra; Laura Gibson; Lawrence J Stern; J Mauricio Calvo-Calle
Journal:  Curr Opin Virol       Date:  2014-10-27       Impact factor: 7.090

4.  Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis.

Authors:  Joshua A Hill; Sophia Koo; Belisa B Guzman Suarez; Vincent T Ho; Corey Cutler; John Koreth; Philippe Armand; Edwin P Alyea; Lindsey R Baden; Joseph H Antin; Robert J Soiffer; Francisco M Marty
Journal:  Biol Blood Marrow Transplant       Date:  2012-05-04       Impact factor: 5.742

Review 5.  Latency, Integration, and Reactivation of Human Herpesvirus-6.

Authors:  Shara N Pantry; Peter G Medveczky
Journal:  Viruses       Date:  2017-07-24       Impact factor: 5.048

Review 6.  Role of viruses in etiology and pathogenesis of multiple sclerosis.

Authors:  S S Soldan; S Jacobson
Journal:  Adv Virus Res       Date:  2001       Impact factor: 9.937

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.